Form 4 for VRNS VARONIS SYSTEMS INC
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-09 · accession 0001213900-24-041857 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-10 | 2024-05-09+ | VRNS | Faitelson Yakov | CEO, Pres, COB, Dir | M - OptEx | $7.54 | +420.0K | 1.74M | +32% | +$3.17M |
| DM | 2024-05-10 | 2024-05-09+ | VRNS | Faitelson Yakov | CEO, Pres, COB, Dir | S - Sale+OE | $45.13 | -331.7K | 1.45M | -19% | -$14.97M |
| DM | 2024-05-10 | 2024-05-09+ | VRNS | Faitelson Yakov | CEO, Pres, COB, Dir | M - OptEx | $0.00 | -420.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2024-05-09 | M | A | 4,374 | $9.96 | 1,440,379 | D | — | — | (F1) The reporting person acquired these shares by the exercise of incentive stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. These shares have not been sold by the reporting person. |
| 2 | Common | Common Stock, par value $0.001 per share | 2024-05-09 | M | A | 12,543 | $5.62 | 1,452,922 | D | — | — | (F1) The reporting person acquired these shares by the exercise of incentive stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. These shares have not been sold by the reporting person. |
| 3 | Common | Common Stock, par value $0.001 per share | 2024-05-09 | M | A | 183,585 | $7.00 | 1,636,507 | D | — | — | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). |
| 4 | Common | Common Stock, par value $0.001 per share | 2024-05-09 | S | D | 284,211 | $45.23 | 1,452,922 | D | — | — | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). |
| 5 | Common | Common Stock, par value $0.001 per share | 2024-05-10 | M | A | 47,457 | $5.62 | 1,500,379 | D | — | — | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). |
| 6 | Common | Common Stock, par value $0.001 per share | 2024-05-10 | S | D | 47,457 | $44.53 | 1,452,922 | D | — | — | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). |
| 7 | Common | Common Stock, par value $0.001 per share | 2024-05-09 | M | A | 71,415 | $7.00 | 1,436,005 | D | — | — | (F1) The reporting person acquired these shares by the exercise of incentive stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. These shares have not been sold by the reporting person. |
| 8 | Common | Common Stock, par value $0.001 per share | 2024-05-09 | M | A | 100,626 | $9.96 | 1,737,133 | D | — | — | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). |
| 9 | Derivative | Stock Option (right to buy) | 2024-05-09 | M | D | 183,585 | $0.00 | 0 | D | $7.00 · — to 2024-08-04 | 183,585 Common Stock | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). (F3) The stock options vested and became exercisable over various vesting schedules reported on the reporting person's prior Form 4s, becoming fully exercisable on the following dates: with respect to the stock options with a $7.00 exercise price, August 7, 2018; with respect to the stock options with a $9.96 exercise price, March 20, 2020; and with respect to the stock options with a $5.6233 exercise price, March 17, 2021. |
| 10 | Derivative | Stock Option (right to buy) | 2024-05-09 | M | D | 12,543 | $0.00 | 47,457 | D | $5.62 · — to 2026-02-14 | 12,543 Common Stock | (F3) The stock options vested and became exercisable over various vesting schedules reported on the reporting person's prior Form 4s, becoming fully exercisable on the following dates: with respect to the stock options with a $7.00 exercise price, August 7, 2018; with respect to the stock options with a $9.96 exercise price, March 20, 2020; and with respect to the stock options with a $5.6233 exercise price, March 17, 2021. (F1) The reporting person acquired these shares by the exercise of incentive stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. These shares have not been sold by the reporting person. |
| 11 | Derivative | Stock Option (right to buy) | 2024-05-09 | M | D | 4,374 | $0.00 | 100,626 | D | $9.96 · — to 2025-02-17 | 4,374 Common Stock | (F3) The stock options vested and became exercisable over various vesting schedules reported on the reporting person's prior Form 4s, becoming fully exercisable on the following dates: with respect to the stock options with a $7.00 exercise price, August 7, 2018; with respect to the stock options with a $9.96 exercise price, March 20, 2020; and with respect to the stock options with a $5.6233 exercise price, March 17, 2021. (F1) The reporting person acquired these shares by the exercise of incentive stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. These shares have not been sold by the reporting person. |
| 12 | Derivative | Stock Option (right to buy) | 2024-05-09 | M | D | 71,415 | $0.00 | 183,585 | D | $7.00 · — to 2024-08-04 | 71,415 Common Stock | (F3) The stock options vested and became exercisable over various vesting schedules reported on the reporting person's prior Form 4s, becoming fully exercisable on the following dates: with respect to the stock options with a $7.00 exercise price, August 7, 2018; with respect to the stock options with a $9.96 exercise price, March 20, 2020; and with respect to the stock options with a $5.6233 exercise price, March 17, 2021. (F1) The reporting person acquired these shares by the exercise of incentive stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. These shares have not been sold by the reporting person. |
| 13 | Derivative | Stock Option (right to buy) | 2024-05-09 | M | D | 100,626 | $0.00 | 0 | D | $9.96 · — to 2025-02-17 | 100,626 Common Stock | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). (F3) The stock options vested and became exercisable over various vesting schedules reported on the reporting person's prior Form 4s, becoming fully exercisable on the following dates: with respect to the stock options with a $7.00 exercise price, August 7, 2018; with respect to the stock options with a $9.96 exercise price, March 20, 2020; and with respect to the stock options with a $5.6233 exercise price, March 17, 2021. |
| 14 | Derivative | Stock Option (right to buy) | 2024-05-10 | M | D | 47,457 | $0.00 | 0 | D | $5.62 · — to 2026-02-14 | 47,457 Common Stock | (F2) The reporting person acquired these shares by the exercise of non-qualifying stock options, certain of which have upcoming expiration dates in August 2024 and February 2025. The reporting person then sold such shares in multiple transactions on May 9, 2024 and May 10, 2024, at prices ranging from $44.75 to $45.62 on May 9, 2024 and $44.28 to $45.18 on May 10, 2024 (with the prices reported for such sales in Column 4 representing a weighted average price). (F3) The stock options vested and became exercisable over various vesting schedules reported on the reporting person's prior Form 4s, becoming fully exercisable on the following dates: with respect to the stock options with a $7.00 exercise price, August 7, 2018; with respect to the stock options with a $9.96 exercise price, March 20, 2020; and with respect to the stock options with a $5.6233 exercise price, March 17, 2021. |